Necrosectomy With Cryotechnology for Accelerated Removal

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

January 30, 2027

Conditions
Pancreatic NecrosisAcute PancreatitisAcute Pancreatic NecrosisNecrosisNecrosis PancreasWalled-Off Pancreatic Necrosis
Interventions
DEVICE

Cryotechnology Necrosectomy Procedure

Subjects undergo necrosectomy with 1.7 mm flexible cryoprobes, either concurrently with stent placement or post-placement, at the Investigator's discretion. The cryoprobe will freeze the necrotic tissue and extracted en-bloc. A maximum of 4 cryotechnology procedures will be performed, with each procedure aiming for significant debris removal and clinical improvement of walled-off pancreatic necrosis (WOPN) symptoms.

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erbe Elektromedizin GmbH

INDUSTRY

lead

Christopher C. Thompson, MD, MSc

OTHER

NCT06553651 - Necrosectomy With Cryotechnology for Accelerated Removal | Biotech Hunter | Biotech Hunter